Author:
Shi Yucong,Wu Sizhi,Ma Shengsuo,Lyu Yiwen,Xu Huachong,Deng Li,Chen Xiaoyin
Funder
Key-Area Research and Development Program of Guangdong Province
Project of Administration of Traditional Chinese Medicine of Guangdong Province
Guangdong Basic and Applied Basic Research Foundation, China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II—ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3):234S-S242.
3. Nakamura H, Kazuyuki S, Kawasaki N, Taguchi M, Kato H. History of limited resection for non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2005;11(6):356–62.
4. Forquer JA, Fakiris AJ, McGarry RC, et al. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy. Exp Rev Anticancer Ther. 2009;9(10):1443–53.
5. Cao C, Gupta S, Chandrakumar D, Tian DH, Black D, Yan TD. Meta-analysis of intentional sublobar resections versus lobectomy for early stage non-small cell lung cancer. Ann Cardiothorac Surg. 2014;3(2):134–41.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献